Grants per year
Personal profile
Education/Academic qualification
Pharmacology & Biomedical Sciences, PhD, University of Portsmouth
… → 2020
Medicine, MD, Bangalore Medical College, India
… → 2010
Fingerprint
Dive into the research topics where Niraj K Shenoy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 2 Active
-
Enhancing the Efficacy of Immunotherapy in Cancer with Ascorbic Acid
Shenoy, N. K. & Luchtel, R. A.
Lotte and John Hecht Memorial Foundation
4/1/22 → 12/31/25
Project: Research project
-
Epigenetic Targeting of Clear Cell Renal Cell Carcinoma
Shenoy, N. K. & Luchtel, R. A.
1/1/21 → 12/31/24
Project: Research project
-
Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer
Aggarwal, R. K., Luchtel, R. A., Machha, V., Tischer, A., Zou, Y., Pradhan, K., Ashai, N., Ramachandra, N., Albanese, J. M., Yang, J. I., Wang, X., Aluri, S., Gordon, S., Aboumohamed, A., Gartrell, B. A., Hafizi, S., Pullman, J. & Shenoy, N., Sep 28 2021, In: Proceedings of the National Academy of Sciences of the United States of America. 118, 39, e2106947118.Research output: Contribution to journal › Article › peer-review
Open Access10 Scopus citations -
Immune evasion in renal cell carcinoma: biology, clinical translation, future directions
Wang, X., Lopez, R., Luchtel, R. A., Hafizi, S., Gartrell, B. & Shenoy, N., Jan 2021, In: Kidney international. 99, 1, p. 75-85 11 p.Research output: Contribution to journal › Review article › peer-review
Open Access13 Scopus citations -
Aggressive myoepithelial carcinoma with EWSR1-POU5F1 fusion highly responsive to Ewing sarcoma combination chemotherapy
Shenoy, N., Dec 15 2020, In: Cancer. 126, 24, p. 5198-5201 4 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Considerations for target oxygen saturation in COVID-19 patients: Are we under-shooting?
Shenoy, N., Luchtel, R. & Gulani, P., Aug 19 2020, In: BMC Medicine. 18, 1, 260.Research output: Contribution to journal › Article › peer-review
Open Access57 Scopus citations -
HIF1α is not a target of 14q deletion in clear cell renal cancer
Shenoy, N., Dec 1 2020, In: Scientific reports. 10, 1, 17642.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations